Navitor™ in Evolut™: a case report illustrating a novel approach to redo-transcatheter aortic valve implantation
Open Access
- 24 October 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 8 (11) , ytae577
Abstract
Transcatheter aortic valve implantation (TAVI) is expanding to younger patients and the management of valve failure is a growing clinical problem. The transcatheter heart valve (THV) of choice for redo - TAVI is a complex decision and first reports have examined the use of the Sapien 3TM THV (Edwards Lifesciences; Irvine, CA, USA) in failed EvolutTM (Medtronic, Minneapolis, MN, USA) THV. However, several different technical approaches may be worth consideration, and the subject remains a matter of debate. A 73-year old female with previous coronary artery by-pass grafting (CABG), percutaneous coronary intervention (PCI) and TAVI with a 26 mm EvolutTM R THV presented with signs of heart failure. The clinical investigation revealed a severe restenosis of the THV valve and a stenosis of the left coronary main stem. The patient was successfully treated with PCI of the left main and, during the same procedure, underwent implantation of a 25 mm NavitorTM THV (Abbott; Chicago, Il, USA). This case presentation aims to illustrate the rationale of and necessary conditions for performing a TAVI-in-TAVI procedure with NavitorTM THV in a failed EvolutTM THV which, to our best knowledge, constitutes a novel approach to redo - TAVI.Keywords
This publication has 10 references indexed in Scilit:
- Feasibility of Coronary Access Following Redo-TAVR for Evolut Failure: A Computed Tomography Simulation StudyCirculation: Cardiovascular Interventions, 2023
- Transcatheter aortic valve implantation in patients with extra-small aortic annuliEuroIntervention, 2023
- Feasibility of redo-TAVI in self-expanding Evolut valves: a CT analysis from the Evolut Low Risk Trial substudyEuroIntervention, 2023
- Balloon-Expandable Valve for Treatment of Evolut Valve FailureJACC: Cardiovascular Interventions, 2022
- Calcific aortic valve disease: from molecular and cellular mechanisms to medical therapyEuropean Heart Journal, 2021
- Valve Academic Research Consortium 3: Updated Endpoint Definitions for Aortic Valve Clinical ResearchJACC, 2021
- The Novel FlexNav Delivery System for Transcatheter Aortic Valve Implantation With the Portico Device: A Case SeriesJournal of Invasive Cardiology, 2021
- Self-expanding intra-annular versus commercially available transcatheter heart valves in high and extreme risk patients with severe aortic stenosis (PORTICO IDE): a randomised, controlled, non-inferiority trialThe Lancet, 2020
- Comprehensive Echocardiographic Assessment of Normal Transcatheter Valve FunctionJACC: Cardiovascular Imaging, 2019
- Changes of the eSheath Outer Dimensions Used for Transfemoral Transcatheter Aortic Valve ReplacementBioMed Research International, 2015